PharmaShots | Incisive News in 3 Shots

Subscribe Now

Asieris Pharmaceuticals

Asieris Reports the P-III Study Results of APL-1702 for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Asieris Reports the P-III Study Results of APL-1702 for Treating Cervical High-Grade Squamous Intraepithelial Lesions

March 18, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us